Page 2 - Precigen News Today

Sanders Morris Harris LLC increased its stake in Precigen, Inc. (NASDAQ:PGEN – Free Report) by 26.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 410,000 shares of the biotechnology company’s stock after purchasing an additional 85,000 shares during the quarter. Sanders Morris Harris LLC […]

Allspring Global Investments Holdings LLC boosted its holdings in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) by 1,092.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,272 shares of the biotechnology company’s stock after purchasing an additional 47,888 shares […]

– Based on FDA confirmation in August 2023 that the ongoing Phase 1/2 single-arm study of PRGN-2012 in RRP will serve as the pivotal study to support BLA...

Precigen, Inc. (NASDAQ:PGEN – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.29 and traded as low as $1.10. Precigen shares last traded at $1.16, with a volume of 889,320 shares changing hands. Wall Street Analysts Forecast Growth Several […]

Equities researchers at StockNews.com initiated coverage on shares of Precigen (NASDAQ:PGEN – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Precigen in a research […]

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Precigen, Inc. (NASDAQ:PGEN – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 13,690,000 shares, an increase of 39.4% from the August 15th total of 9,820,000 shares. Based on an average trading volume of 1,670,000 shares, the […]

StockNews.com started coverage on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the stock. JPMorgan Chase & Co. assumed coverage on shares of Precigen in […]

Unraveling the Complexities of Precigen Inc's Financial Metrics

StockNews.com assumed coverage on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Several other brokerages have also issued reports on PGEN. HC Wainwright restated a buy rating and issued a $6.00 target price on shares of […]